With respect to pancreatic cancer, previous studies reported divergent tumoral PD-L1 levels, ranging from 12 to 90%.5,25,26 This variance in PD-L1 levels may result from the specificity of the detection methods, the quality of the samples and the quality and sensitivity of the detection antibody. Here, CD274 is linked to familial pancreatic carcinoma.